Billerica, Massachusetts-based Insulet Corporation, maker of the OmniPod Insulin pump, has just announced that it received the FDA clearance to commercialize its latest product the Omnipod Dash Insulin Management System.
from MobiHealthNews https://ift.tt/2kNtYbe
June 05, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Entrepreneur to head ATA, and other digital health hires and departuresAnn Mond Johnson will be taking over as CEO of the the American Telemedicine Association in early March, according to a statement released last week. She previously served as the CEO of Zest Health, served as board … Read More
Study: COPD robot improves medication adherence, but no effect on admissionsA socially assistive robot could be key to helping people with COPD manage their condition at home. A recent study published in JMIR, found that COPD patients that had a take-home a robot following a hospitalization were more… Read More
Roche acquires oncology EHR company Flatiron Health for $1.9BPharma giant Roche is set to acquire oncology EHR software firm Flatiron Health in the first half of 2018, the companies announced today in a statement. Roche will pay an additional $1.9 billion over the millions it had alrea… Read More
Tips for hospitals to succeed in the age of consumerismThe rise of consumerism in healthcare might seem like new ground to people in the industry, but when other industries are considered, that ground starts to look well-trodden. Customer service, customer satisfaction, and custo… Read More
FareWell changes name to Better Therapeutics, sees 0.8 percent A1c reduction in small studySan Francisco-based FareWell is changing its name to Better Therapeutics, a rebranding that reflects the company’s shift in focus from weight loss and disease prevention to digital therapeutics to treat chronic diseases. fro… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment